ArticleJournal for immunotherapy of cancer2026

From controversy to opportunity: experts weigh in on myeloid states as determinants in cancer immunotherapy.

Jennifer L Guerriero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.